Table 7 Cumulative incidence of relapse... | American Society of Hematology

Table 7

Cumulative incidence of relapse*

	M3, n (%)			M3V, n (%)			P
	n	5-year	10-year	n	5-year	10-year	P
I0129	120	33 (4.3)	35 (4.4)	19	37 (11.4)	37 (11.4)	.9
LPA96	133	15 (3.1)	15 (3.1)	23	39 (10.5)	39 (10.5)	.005
LPA99	416	9 (1.4)	—	85	18 (4.2)	—	.03
ALL	669	15 (1.4)	—	127	24 (3.8)	—	.005†
Relapse risk							.84‡
Low	169	9.5 (2.3)	9.5 (2.3)	20	15 (8.2)	15 (8.2)	.64†
Intermediate	402	12 (1.6)	13 (1.8)	35	14 (6)	14 (6)	.71†
High	98	35 (4.9)	—	72	32 (5.5)	—	.62†

	M3, n (%)			M3V, n (%)			P
	n	5-year	10-year	n	5-year	10-year	P
I0129	120	33 (4.3)	35 (4.4)	19	37 (11.4)	37 (11.4)	.9
LPA96	133	15 (3.1)	15 (3.1)	23	39 (10.5)	39 (10.5)	.005
LPA99	416	9 (1.4)	—	85	18 (4.2)	—	.03
ALL	669	15 (1.4)	—	127	24 (3.8)	—	.005†
Relapse risk							.84‡
Low	169	9.5 (2.3)	9.5 (2.3)	20	15 (8.2)	15 (8.2)	.64†
Intermediate	402	12 (1.6)	13 (1.8)	35	14 (6)	14 (6)	.71†
High	98	35 (4.9)	—	72	32 (5.5)	—	.62†

Standard error given in parentheses.

Taking nonrelapse death as a competing risk.

Stratified by study (I0129, LPA96, LPA99).

Stratified by relapse risk.